85 related articles for article (PubMed ID: 12697500)
41. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
[TBL] [Abstract][Full Text] [Related]
42. Interactions of myeloma cells with osteoclasts promote tumour expansion and bone degradation through activation of a complex signalling network and upregulation of cathepsin K, matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA).
Hecht M; von Metzler I; Sack K; Kaiser M; Sezer O
Exp Cell Res; 2008 Mar; 314(5):1082-93. PubMed ID: 18053985
[TBL] [Abstract][Full Text] [Related]
43. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.
Spencer GJ; Utting JC; Etheridge SL; Arnett TR; Genever PG
J Cell Sci; 2006 Apr; 119(Pt 7):1283-96. PubMed ID: 16522681
[TBL] [Abstract][Full Text] [Related]
44. [Effects of fluoride on osteoclastic activity of rats in vitro].
Hua K; Bu LS; Li GS
Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Jul; 37(4):256-8. PubMed ID: 12930675
[TBL] [Abstract][Full Text] [Related]
45. Endogenous expression and endocytosis of tartrate-resistant acid phosphatase (TRACP) by osteoblast-like cells.
Perez-Amodio S; Vogels IM; Schoenmaker T; Jansen DC; Alatalo SL; Halleen JM; Beertsen W; Everts V
Bone; 2005 Jun; 36(6):1065-77. PubMed ID: 15878315
[TBL] [Abstract][Full Text] [Related]
46. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts.
Kitamura K; Takahira K; Inari M; Satoh Y; Hayakawa K; Tabuchi Y; Ogai K; Nishiuchi T; Kondo T; Mikuni-Takagaki Y; Chen W; Hattori A; Suzuki N
Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep; 166(1):74-80. PubMed ID: 23632157
[TBL] [Abstract][Full Text] [Related]
47. Disruption of the Man-6-P targeting pathway in mice impairs osteoclast secretory lysosome biogenesis.
van Meel E; Boonen M; Zhao H; Oorschot V; Ross FP; Kornfeld S; Klumperman J
Traffic; 2011 Jul; 12(7):912-24. PubMed ID: 21466643
[TBL] [Abstract][Full Text] [Related]
48. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
49. Fluorescence-based staining for tartrate-resistant acidic phosphatase (TRAP) in osteoclasts combined with other fluorescent dyes and protocols.
Filgueira L
J Histochem Cytochem; 2004 Mar; 52(3):411-4. PubMed ID: 14966208
[TBL] [Abstract][Full Text] [Related]
50. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
Sasaki T
Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
[TBL] [Abstract][Full Text] [Related]
51. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.
Chu K; Snyder R; Econs MJ
J Bone Miner Res; 2006 Jul; 21(7):1089-97. PubMed ID: 16813529
[TBL] [Abstract][Full Text] [Related]
52. Bioactivity of xerogels as modulators of osteoclastogenesis mediated by connexin 43.
Glenske K; Wagner AS; Hanke T; Cavalcanti-Adam EA; Heinemann S; Heinemann C; Kruppke B; Arnhold S; Moritz A; Schwab EH; Worch H; Wenisch S
Biomaterials; 2014 Feb; 35(5):1487-95. PubMed ID: 24268200
[TBL] [Abstract][Full Text] [Related]
53. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis.
Gravallese EM; Harada Y; Wang JT; Gorn AH; Thornhill TS; Goldring SR
Am J Pathol; 1998 Apr; 152(4):943-51. PubMed ID: 9546355
[TBL] [Abstract][Full Text] [Related]
54. Effects of inorganic mercury and methylmercury on osteoclasts and osteoblasts in the scales of the marine teleost as a model system of bone.
Yachiguchi K; Sekiguchi T; Nakano M; Hattori A; Yamamoto M; Kitamura K; Maeda M; Tabuchi Y; Kondo T; Kamauchi H; Nakabayashi H; Srivastav AK; Hayakawa K; Sakamoto T; Suzuki N
Zoolog Sci; 2014 May; 31(5):330-7. PubMed ID: 24832906
[TBL] [Abstract][Full Text] [Related]
55. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation.
Wutzl A; Brozek W; Lernbass I; Rauner M; Hofbauer G; Schopper C; Watzinger F; Peterlik M; Pietschmann P
J Biomed Mater Res A; 2006 Apr; 77(1):75-83. PubMed ID: 16355411
[TBL] [Abstract][Full Text] [Related]
56. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
Hill PA; Reynolds JJ; Meikle MC
Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
[TBL] [Abstract][Full Text] [Related]
57. Localization of cathepsin K and tartrate-resistant acid phosphatase in synovium and cranial cruciate ligament in dogs with cruciate disease.
Muir P; Schamberger GM; Manley PA; Hao Z
Vet Surg; 2005; 34(3):239-46. PubMed ID: 16115080
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of tartrate-resistant acid phosphatase and cathepsin K in ruptured cranial cruciate ligaments in dogs.
Muir P; Hayashi K; Manley PA; Colopy SA; Hao Z
Am J Vet Res; 2002 Sep; 63(9):1279-84. PubMed ID: 12224861
[TBL] [Abstract][Full Text] [Related]
59. Differential expression of monomeric and proteolytically processed forms of tartrate-resistant acid phosphatase in rat tissues.
Lång P; Andersson G
Cell Mol Life Sci; 2005 Apr; 62(7-8):905-18. PubMed ID: 15761664
[TBL] [Abstract][Full Text] [Related]
60. Increased osteoclast activity in the presence of increased homocysteine concentrations.
Herrmann M; Widmann T; Colaianni G; Colucci S; Zallone A; Herrmann W
Clin Chem; 2005 Dec; 51(12):2348-53. PubMed ID: 16195358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
